JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,688,000 | -22.8% | 1,148,780 | 0.0% | 1.17% | -17.6% |
| Q2 2022 | $3,481,000 | -55.4% | 1,148,780 | 0.0% | 1.42% | -32.7% |
| Q1 2022 | $7,800,000 | -18.7% | 1,148,780 | 0.0% | 2.12% | -11.8% |
| Q4 2021 | $9,592,000 | -57.7% | 1,148,780 | -62.3% | 2.40% | -44.2% |
| Q3 2021 | $22,652,000 | +9.3% | 3,048,780 | 0.0% | 4.30% | +18.8% |
| Q2 2021 | $20,732,000 | -33.8% | 3,048,780 | 0.0% | 3.62% | -8.6% |
| Q1 2021 | $31,311,000 | +46.7% | 3,048,780 | 0.0% | 3.96% | +116.1% |
| Q4 2020 | $21,342,000 | -14.2% | 3,048,780 | 0.0% | 1.83% | -12.3% |
| Q3 2020 | $24,878,000 | +18.3% | 3,048,780 | 0.0% | 2.09% | -31.9% |
| Q2 2020 | $21,037,000 | +45.3% | 3,048,780 | 0.0% | 3.07% | -22.1% |
| Q1 2020 | $14,482,000 | -45.6% | 3,048,780 | 0.0% | 3.94% | -66.5% |
| Q4 2019 | $26,616,000 | +162.2% | 3,048,780 | 0.0% | 11.75% | +104.3% |
| Q3 2019 | $10,152,000 | -32.7% | 3,048,780 | 0.0% | 5.75% | -10.3% |
| Q2 2019 | $15,091,000 | -20.2% | 3,048,780 | 0.0% | 6.42% | -30.7% |
| Q1 2019 | $18,902,000 | +84.0% | 3,048,780 | 0.0% | 9.26% | +7.6% |
| Q4 2018 | $10,274,000 | -48.2% | 3,048,780 | 0.0% | 8.61% | -2.7% |
| Q3 2018 | $19,817,000 | -15.1% | 3,048,780 | 0.0% | 8.85% | +13.8% |
| Q2 2018 | $23,354,000 | -65.7% | 3,048,780 | 0.0% | 7.78% | -68.3% |
| Q1 2018 | $68,140,000 | +75.3% | 3,048,780 | 0.0% | 24.53% | +80.2% |
| Q4 2017 | $38,872,000 | – | 3,048,780 | – | 13.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |